JP2022548158A5 - - Google Patents

Info

Publication number
JP2022548158A5
JP2022548158A5 JP2022517199A JP2022517199A JP2022548158A5 JP 2022548158 A5 JP2022548158 A5 JP 2022548158A5 JP 2022517199 A JP2022517199 A JP 2022517199A JP 2022517199 A JP2022517199 A JP 2022517199A JP 2022548158 A5 JP2022548158 A5 JP 2022548158A5
Authority
JP
Japan
Prior art keywords
carbon atoms
fewer
alkyl
fewer carbon
heteroarylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022517199A
Other languages
English (en)
Japanese (ja)
Other versions
JP7591040B2 (ja
JP2022548158A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051325 external-priority patent/WO2021055639A1/en
Publication of JP2022548158A publication Critical patent/JP2022548158A/ja
Publication of JP2022548158A5 publication Critical patent/JP2022548158A5/ja
Priority to JP2024172134A priority Critical patent/JP2024177285A/ja
Application granted granted Critical
Publication of JP7591040B2 publication Critical patent/JP7591040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022517199A 2019-09-18 2020-09-17 リン酸化タウタンパク質への結合を介した神経障害を検出する方法 Active JP7591040B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024172134A JP2024177285A (ja) 2019-09-18 2024-10-01 リン酸化タウタンパク質への結合を介した神経障害を検出する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962902265P 2019-09-18 2019-09-18
US62/902,265 2019-09-18
PCT/US2020/051325 WO2021055639A1 (en) 2019-09-18 2020-09-17 Methods of detecting neurological disorders via binding to phosphorylated tau protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024172134A Division JP2024177285A (ja) 2019-09-18 2024-10-01 リン酸化タウタンパク質への結合を介した神経障害を検出する方法

Publications (3)

Publication Number Publication Date
JP2022548158A JP2022548158A (ja) 2022-11-16
JP2022548158A5 true JP2022548158A5 (cg-RX-API-DMAC7.html) 2023-11-13
JP7591040B2 JP7591040B2 (ja) 2024-11-27

Family

ID=74883484

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517199A Active JP7591040B2 (ja) 2019-09-18 2020-09-17 リン酸化タウタンパク質への結合を介した神経障害を検出する方法
JP2024172134A Pending JP2024177285A (ja) 2019-09-18 2024-10-01 リン酸化タウタンパク質への結合を介した神経障害を検出する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024172134A Pending JP2024177285A (ja) 2019-09-18 2024-10-01 リン酸化タウタンパク質への結合を介した神経障害を検出する方法

Country Status (7)

Country Link
US (1) US20220370642A1 (cg-RX-API-DMAC7.html)
EP (1) EP4031879A4 (cg-RX-API-DMAC7.html)
JP (2) JP7591040B2 (cg-RX-API-DMAC7.html)
CN (1) CN114729945B (cg-RX-API-DMAC7.html)
AU (1) AU2020348382A1 (cg-RX-API-DMAC7.html)
CA (1) CA3154481A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021055639A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019279001B2 (en) 2018-05-31 2025-11-27 Amydis, Inc. Compositions and methods for detection of traumatic brain injury
US20250282723A1 (en) * 2021-06-16 2025-09-11 The Regents Of The University Of California Amyloid targeting agents and methods of using the same
US20240325572A1 (en) * 2021-07-15 2024-10-03 Amydis, Inc. N-heterocyclyl substituted 2-cyano-3-(naphthalen-2-yl)acrylamide derivatives as fluorophors for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102115429B (zh) * 2010-01-06 2013-02-27 中国科学院上海药物研究所 (e)-1-(3,5-二甲氧基苯基)-2-(3,5-二羟基-4-甲氧基苯基)乙烯及其制备方法和用途
CA2815960C (en) * 2010-10-29 2019-01-22 Clino Ltd. Tau imaging probe
CN106573880B (zh) * 2014-03-19 2019-07-30 阿米达斯公司 淀粉样蛋白靶向剂及其使用方法
EP3191107A2 (en) * 2014-09-12 2017-07-19 Amydis Diagnostics, Inc. In vitro compositions comprising human sample and amyloid targeting agent
JP7029718B2 (ja) * 2017-07-31 2022-03-04 国立研究開発法人量子科学技術研究開発機構 リン酸化タウタンパク質の測定方法
AU2019279001B2 (en) * 2018-05-31 2025-11-27 Amydis, Inc. Compositions and methods for detection of traumatic brain injury
AU2019372432B2 (en) * 2018-11-02 2025-05-29 Amydis, Inc. Phosphate compounds for detecting neurological disorders

Similar Documents

Publication Publication Date Title
US11160880B2 (en) Compositions and methods for assessing eye vasculature
JP2023529354A5 (cg-RX-API-DMAC7.html)
JP2003520215A5 (cg-RX-API-DMAC7.html)
JP2012509902A5 (cg-RX-API-DMAC7.html)
JP2021525875A5 (cg-RX-API-DMAC7.html)
JP2013540114A5 (cg-RX-API-DMAC7.html)
JP2003520868A5 (cg-RX-API-DMAC7.html)
JP7695789B2 (ja) ホスホ抗原プロドラッグ化合物
JP2017531689A5 (cg-RX-API-DMAC7.html)
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2004511531A (ja) 器官機能の即時測定用の光感受性化合物
JP7089062B2 (ja) 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Bclファミリーアンタゴニストであるホスホリジン
JP2024525693A5 (cg-RX-API-DMAC7.html)
JP7583895B2 (ja) 外傷性脳損傷を検出するための組成物および方法
JP2004525863A (ja) 動的な器官機能のモニタリング物質
JP2024177285A (ja) リン酸化タウタンパク質への結合を介した神経障害を検出する方法
JP2025511875A5 (cg-RX-API-DMAC7.html)
JP2023552490A5 (cg-RX-API-DMAC7.html)
JP2004513893A (ja) 器官機能モニタリング用の新規染料
JP2024503898A5 (cg-RX-API-DMAC7.html)
JP2023543993A5 (cg-RX-API-DMAC7.html)
JP2020520393A5 (cg-RX-API-DMAC7.html)
JP2024522201A5 (cg-RX-API-DMAC7.html)
JP2749593B2 (ja) 穏和安定薬組成物
RU2006103790A (ru) Производные такрина в качестве ингибиторов ацетилхолинэстеразы